Mana Hyderabad based Bharat Biotech ane company Covid 19 ki vaccine ni produce chese process lo unnaru, Phase 1,2 clinical trials kosam Drug Controller General of India (DCGI) nunchi clearance kuda vachindi.
It is the first Indian pharmaceutical company to launch human trails of their inactivated vaccine COVAXIN
Now, The Indian Council of Medical Research (ICMR) has set an launch date of August 15 for the public use of the Coronavirus vaccine being developed in partnership with Bharat Biotech.
A letter by ICMR Director General Balram Bhargava garu…
The ICMR has selected 12 institutes for clinical trial of the country’s first COVID-19 vaccine. The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune.
The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.
Dr Anant Bhan, researcher global health, bioethics and health policy, said that…
“Such an accelerated development pathway has not been done ever for any vaccine, even for the ones being tried out in other countries. Even with accelerated timelines, this seems really rushed and hence with potential risks.”
He raised some issues with this letter in his twitter thread…
This is a letter which has been sent out by the ICMR DG yesterday. Now that multiple folks have confirmed genuineness, let me raise some issues with this letter on #vaccine #trials during a pandemic, in this case #COVID19
What are the ethical issues in this letter? Read on. pic.twitter.com/EaJkeaHjmV
— Anant Bhan (@AnantBhan) July 3, 2020
Incharge of the clinical trial in SRM Hospital and Research Centre, Tamil Nadu, Satyajit Mohapatra said that…
“ICMR has given a timeframe for completion of Phase 1 of the trial by August. Phase 2 of the study will start after completion of Phase 1, followed by Phase 3.”
The Phase 1 is planned for completion in 28 days, which would meet the August 15 deadline. It is not clear how the vaccine can be made available for public use with just the results of the first phase.
Dr Krishna Ella, the Chairman and Managing Director of Bharat Biotech, said that…
“I hope like in other countries, some processes would be skipped to ensure quicker delivery of the vaccine. I can’t give a timeline, but hope the vaccine is only a few months away,”
Lets hope for the good and safe days, if successful, this would be the first vaccine in the world available for commercial use in the fight against Covid-19.
If you wish to contribute, mail us at firstname.lastname@example.org